Archive for 'Urology' Category
Sipuleucel-T (Provenge), The First FDA-Approved Cancer "Vaccine" – What Every Medical Student Should Know
By medliorator - Last updated: Tuesday, May 4, 2010
Here are the bare bones facts on Provenge. A basic understanding will help you to stand out when the discussion inevitably comes up. Drug Name: Sipuleucel-T Trade Name: Provenge Trial Name: APC 8015 Manufacturer: Dendreon Corporation Class: autologous, dendritic cell-based immunotherapy Indication: hormone-refractory, metastatic prostate cancer MOA: Induces patient’s own cells to attack prostate cancer. [...]
